Potential role of Borreria hispida in ameliorating cardiovascular risk factors

Hannah R. Vasanthi, Subhendu Mukherjee, I. Lekli, Diptarka Ray, Gayathri Veeraraghavan, Dipak K. Das

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Borreria hispida (BHE), a weed of Rubiaceae family, is being used from time immemorial as an alternative therapy for diabetes. To evaluate the scientific background of using BHE as therapy to reduce cardiovascular risk, a group of rats were given BHE for a period of 30 days, whereas control animals were given the vehicle only. The animals were sacrificed, the hearts were isolated, and perfused with buffer. All the hearts were subjected to 30-minute ischemia followed by 2-hour reperfusion. Compared with vehicle-treated rats, BHE-treated rat hearts showed improved post-ischemic ventricular function and exhibited reduced myocardial infarct size and cardiomyocyte apoptosis. The level of cytochrome c expression and caspase 3 activation was also reduced. BHE elevated antiapoptotic proteins Bcl-2 and heme oxygenase-1 and stimulated the phosphorylation of survival protein Akt simultaneously decreasing the apoptotic proteins Bax and Src. In addition, BHE enhanced the protein expression of peroxisome proliferator-activated receptor-γ, peroxisome proliferator-activated receptor-δ, and Glut-4, probably revealing the antiobese and antidiabetic potential of BHE. These results indicate that treatment with BHE improves cardiac function and ameliorates various risk factors associated with cardiac disease, suggesting that BHE can be considered as a potential plant-based nutraceutical and pharmaceutical agent for the management of cardiovascular diseases.

Original languageEnglish
Pages (from-to)499-506
Number of pages8
JournalJournal of Cardiovascular Pharmacology
Volume53
Issue number6
DOIs
Publication statusPublished - Jun 2009

Fingerprint

Peroxisome Proliferator-Activated Receptors
bcl-2-Associated X Protein
Rubiaceae
Proteins
Heme Oxygenase-1
Ventricular Function
Complementary Therapies
Dietary Supplements
Hypoglycemic Agents
Cardiac Myocytes
Caspase 3
Reperfusion
Heart Diseases
Buffers
Cardiovascular Diseases
Ischemia
Myocardial Infarction
Phosphorylation
Apoptosis
Therapeutics

Keywords

  • Borreria hispida
  • Cardioprotection
  • Ischemia
  • Reperfusion
  • Survival signal

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Cite this

Potential role of Borreria hispida in ameliorating cardiovascular risk factors. / Vasanthi, Hannah R.; Mukherjee, Subhendu; Lekli, I.; Ray, Diptarka; Veeraraghavan, Gayathri; Das, Dipak K.

In: Journal of Cardiovascular Pharmacology, Vol. 53, No. 6, 06.2009, p. 499-506.

Research output: Contribution to journalArticle

Vasanthi, Hannah R. ; Mukherjee, Subhendu ; Lekli, I. ; Ray, Diptarka ; Veeraraghavan, Gayathri ; Das, Dipak K. / Potential role of Borreria hispida in ameliorating cardiovascular risk factors. In: Journal of Cardiovascular Pharmacology. 2009 ; Vol. 53, No. 6. pp. 499-506.
@article{2e25fabe150c4064b548671d38007054,
title = "Potential role of Borreria hispida in ameliorating cardiovascular risk factors",
abstract = "Borreria hispida (BHE), a weed of Rubiaceae family, is being used from time immemorial as an alternative therapy for diabetes. To evaluate the scientific background of using BHE as therapy to reduce cardiovascular risk, a group of rats were given BHE for a period of 30 days, whereas control animals were given the vehicle only. The animals were sacrificed, the hearts were isolated, and perfused with buffer. All the hearts were subjected to 30-minute ischemia followed by 2-hour reperfusion. Compared with vehicle-treated rats, BHE-treated rat hearts showed improved post-ischemic ventricular function and exhibited reduced myocardial infarct size and cardiomyocyte apoptosis. The level of cytochrome c expression and caspase 3 activation was also reduced. BHE elevated antiapoptotic proteins Bcl-2 and heme oxygenase-1 and stimulated the phosphorylation of survival protein Akt simultaneously decreasing the apoptotic proteins Bax and Src. In addition, BHE enhanced the protein expression of peroxisome proliferator-activated receptor-γ, peroxisome proliferator-activated receptor-δ, and Glut-4, probably revealing the antiobese and antidiabetic potential of BHE. These results indicate that treatment with BHE improves cardiac function and ameliorates various risk factors associated with cardiac disease, suggesting that BHE can be considered as a potential plant-based nutraceutical and pharmaceutical agent for the management of cardiovascular diseases.",
keywords = "Borreria hispida, Cardioprotection, Ischemia, Reperfusion, Survival signal",
author = "Vasanthi, {Hannah R.} and Subhendu Mukherjee and I. Lekli and Diptarka Ray and Gayathri Veeraraghavan and Das, {Dipak K.}",
year = "2009",
month = "6",
doi = "10.1097/FJC.0b013e3181a7b677",
language = "English",
volume = "53",
pages = "499--506",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Potential role of Borreria hispida in ameliorating cardiovascular risk factors

AU - Vasanthi, Hannah R.

AU - Mukherjee, Subhendu

AU - Lekli, I.

AU - Ray, Diptarka

AU - Veeraraghavan, Gayathri

AU - Das, Dipak K.

PY - 2009/6

Y1 - 2009/6

N2 - Borreria hispida (BHE), a weed of Rubiaceae family, is being used from time immemorial as an alternative therapy for diabetes. To evaluate the scientific background of using BHE as therapy to reduce cardiovascular risk, a group of rats were given BHE for a period of 30 days, whereas control animals were given the vehicle only. The animals were sacrificed, the hearts were isolated, and perfused with buffer. All the hearts were subjected to 30-minute ischemia followed by 2-hour reperfusion. Compared with vehicle-treated rats, BHE-treated rat hearts showed improved post-ischemic ventricular function and exhibited reduced myocardial infarct size and cardiomyocyte apoptosis. The level of cytochrome c expression and caspase 3 activation was also reduced. BHE elevated antiapoptotic proteins Bcl-2 and heme oxygenase-1 and stimulated the phosphorylation of survival protein Akt simultaneously decreasing the apoptotic proteins Bax and Src. In addition, BHE enhanced the protein expression of peroxisome proliferator-activated receptor-γ, peroxisome proliferator-activated receptor-δ, and Glut-4, probably revealing the antiobese and antidiabetic potential of BHE. These results indicate that treatment with BHE improves cardiac function and ameliorates various risk factors associated with cardiac disease, suggesting that BHE can be considered as a potential plant-based nutraceutical and pharmaceutical agent for the management of cardiovascular diseases.

AB - Borreria hispida (BHE), a weed of Rubiaceae family, is being used from time immemorial as an alternative therapy for diabetes. To evaluate the scientific background of using BHE as therapy to reduce cardiovascular risk, a group of rats were given BHE for a period of 30 days, whereas control animals were given the vehicle only. The animals were sacrificed, the hearts were isolated, and perfused with buffer. All the hearts were subjected to 30-minute ischemia followed by 2-hour reperfusion. Compared with vehicle-treated rats, BHE-treated rat hearts showed improved post-ischemic ventricular function and exhibited reduced myocardial infarct size and cardiomyocyte apoptosis. The level of cytochrome c expression and caspase 3 activation was also reduced. BHE elevated antiapoptotic proteins Bcl-2 and heme oxygenase-1 and stimulated the phosphorylation of survival protein Akt simultaneously decreasing the apoptotic proteins Bax and Src. In addition, BHE enhanced the protein expression of peroxisome proliferator-activated receptor-γ, peroxisome proliferator-activated receptor-δ, and Glut-4, probably revealing the antiobese and antidiabetic potential of BHE. These results indicate that treatment with BHE improves cardiac function and ameliorates various risk factors associated with cardiac disease, suggesting that BHE can be considered as a potential plant-based nutraceutical and pharmaceutical agent for the management of cardiovascular diseases.

KW - Borreria hispida

KW - Cardioprotection

KW - Ischemia

KW - Reperfusion

KW - Survival signal

UR - http://www.scopus.com/inward/record.url?scp=68249103436&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68249103436&partnerID=8YFLogxK

U2 - 10.1097/FJC.0b013e3181a7b677

DO - 10.1097/FJC.0b013e3181a7b677

M3 - Article

C2 - 19455054

AN - SCOPUS:68249103436

VL - 53

SP - 499

EP - 506

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

IS - 6

ER -